NeuroCuple to Mitigate Post-Wisdom Teeth Extraction Opioid Risks
Key facts
- Who runs it
- nCap Medical
- Where
- Pittsburgh, United StatesSee the site
- Trial code
- Status
- Not yet recruiting
- People taking part
- 120 people, planned
- Started
- 30 Jun 2026
- Expected to end
- 30 Sept 2027
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- NEUROCUPLE™ Patch
- Sham Patch
- Record updated
- 31 March 2026
Who can take part
- Age
- 18 years to 50 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 22 criteriaShow less
Who can take part
- Males and females of all races and ethnicity
- >18 to 50 years
- Healthy based on medical history
- Scheduled for elective extraction of one or more partially or fully impacted mandibular third molars
- Able to understand and sign the informed consent form
- Willing and able to comply with all study procedures
- Available for the duration of the study
- Able to understand the directions for data gathering instruments
Who cannot take part
- Other concomitant surgery being performed in addition to third molar extraction
- Currently taking CYP3A4 inhibitors, azole-antifungal agents, protease inhibitors, or CNS depressants
- Active alcoholism or illicit drug abuse (defined as daily use of illicit drugs)
- History of gastrointestinal bleeding and/or peptic ulcer, renal disease (excluding kidney stones), hepatic disease, bleeding disorder, respiratory depression
- History of respiratory depression with opioids or other anesthetic drugs that required postoperative ventilatory support or naloxone
- Known allergy to ibuprofen, acetaminophen, oxycodone, hydrocodone, and/or anesthesia
- History of substance or alcohol abuse
- History of substance or alcohol abuse in a first-degree relative
- Children (< 18 years of age)
- T-score ≥ 60 in any of the three PROMIS measures (i.e., sleep, anxiety, and depression)
- Active or untreated asthma
- Consumes three or more alcoholic drinks per day
- No more than one opioid prescription filled within the past 12 months (self-report and PDMP)
- Pregnant or lactating women; Sex, race, and ethnicity will not be used as exclusion criteria
The main criteria, as questions
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 50 years old?
Where in United States
- University of Pittsburgh School of Dental MedicinePittsburgh, United StatesContact: Dan Hawkins, DMD, FACSNot yet recruiting
About the trial
What the trial wants to find out
This is a randomized (1:1), placebo-controlled clinical trial that will examine the feasibility and effectiveness of a 2-day application of the NeuroCuple device for pain relief and reduction of opioid use following wisdom teeth extraction. The primary objectives are to determine whether the active NeuroCuple reduces postoperative pain and decreases opioid consumption compared to a sham (placebo) device. A total of 120 participants will be enrolled over a 1-year period and randomized to receive either the active device or an identical-appearing placebo device without the captor array layer.
The 2 groups in the trial
- NEUROCUPLE™ GroupTreatment being tested
This arm of subjects will receive the active NEUROCUPLE™ patch to wear for 2-days following their Wisdom Teeth Extraction procedure
Treatment: NEUROCUPLE™ Patch
- Sham GroupSham treatment, for comparison
This arm of subjects will receive the placebo (non-active, sham) patch to wear for 2-days following their Wisdom Tooth Extraction procedure
Treatment: Sham Patch
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Mitigating Opioid Use Disorder Risk With Enhanced Opioid Sparing Pain Relief for Wisdom Teeth Extractions With a Novel Nanotechnology
- Criteria questions
- Built from NCT07461506, who can take part
- Record updated
- 31 March 2026